Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. [electronic resource]
Producer: 20080912Description: 930-3 p. digitalISSN:- 1592-8721
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- B-Lymphocytes -- metabolism
- Disease-Free Survival
- Female
- Humans
- Immunologic Factors -- administration & dosage
- Male
- Middle Aged
- Platelet Count
- Purpura, Thrombocytopenic, Idiopathic -- drug therapy
- Rituximab
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.